SARS-CoV-2 infection testing at delivery: a clinical and epidemiological priority.
Enrico Mario FerrazziPaolo BerettaStefano BianchiIrene CetinPaolo GuarnerioAnna LocatelliAnna Maria MarconiMario Giuseppe MeroniGiulia PavoneArmando PintucciFederico PrefumoValeria SavasiArsenio SpinilloBeatrice TassisPatrizia VerganiMichele VignaliFabio ParazziniCarlo La VecchiaPublished in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2020)
During the period 10-26 April, all consecutive women admitted for delivery at the Maternity Hospitals of the city of Milan and in six provinces of Lombardy: Brescia, Como, Lecco Monza, Pavia, and Sondrio. areas were tested with nasopharyngeal swabs. Results and conclusion: Out of 1566 women, 49 were tested positive for SARS-Cov-2 (3.1%, 95% Confidence Interval (CI) 2.3-4.0). This value is largely higher than Heath Authorities estimate. Of tested positive women, 22 (44.9%) had symptoms or reported close contacts with positive patients, that is were found at risk by the itemized questionnaire. In conclusion, routine estimate of frequency of positivity among delivering women can be consider a useful methods to monitor positivity at least in females in their fertile ages.